Inhibitory effect of acetylshikonin on human gastric carcinoma cell line SGC-7901 in vitro and in vivo

World Journal of Gastroenterology

Volumn 15, Issue 15, 2009, Pages 1816-1820

  Zeng, Yun ^a,b   Liu, Gang ^a,b   Zhou, Li Ming ^a  

^a SICHUAN UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Acetylshikonin; Antitumor effect; Apoptosis; SGC 7901 cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLSHIKONIN; ANTINEOPLASTIC AGENT; PROTEIN BAX; PROTEIN BCL 2; SHIKONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN SGC 7901; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOMA; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTHRAQUINONES; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS;

EID: 67651250306     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1816     Document Type: Article

References (24)

1. Scripture CD, Figg WD. Drug interactions in cancer therapy. Nat Rev Cancer 2006; 6: 546-558
2. Sun X, Mu R, Zhou Y, Dai X, Qiao Y, Zhang S, Huang X, Sun J, Li L, Lu F. 1990-1992 mortality of stomach cancer in China. Zhonghua Zhongliu Zazhi 2002; 24: 4-8
3. Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, Liu SZ, Duan WJ. Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol 2003; 9: 2400-2403
4. Macdonald JS. Clinical overview: adjuvant therapy of gastrointestinal cancer. Cancer Chemother Pharmacol 2004; 54 Suppl 1: S4-11
5. Yu W, Kim HS, Choi GS, Suh IS. Perigastric lymph nodes with metastasis in gastric cancer. Hepatogastroenterology 1999; 46: 2658-2661
6. Morse MA, Stoner GD. Cancer chemoprevention: principles and prospects. Carcinogenesis 1993; 14: 1737-1746
7. Lu PJ, Yang C, Lin CN, Li CF, Chu CC, Wang JJ, Chen JY. Shiunko and acetylshikonin promote reepithelialization, angiogenesis, and granulation tissue formation in wounded skin. Am J Chin Med 2008; 36: 115-123
8. Wang JP, Tsao LT, Raung SL, Hsu MF, Kuo SC. Investigation of the inhibition by acetylshikonin of the respiratory burst in rat neutrophils. Br J Pharmacol 1997; 121: 409-416
9. Pietrosiuk A, Furmanowa M, Skopińiska-Rózewska E, Sommer E, Skurzak H, Bany J. The effect of acetylshikonin isolated from Lithospermum canescens roots on tumor-induced cutaneous angiogenesis. Acta Pol Pharm 2004; 61: 379-382
10. Zeng Y, Luo G, Yang W, Zhou L. Inhibitory effect of acetylshikonin injection on mouse S180 sarcoma. Zhongyao Yaoli Yu Linchuang 2008; 24: 22-23
11. Luo G, Guan X, Zhou L. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol Ther 2008; 7: 966-973
12. Qu ZH, Zhang XL, Tang TT, Dai KR. Promotion of osteogenesis through beta-catenin signaling by desferrioxamine. Biochem Biophys Res Commun 2008; 370: 332-337
13. Zeng Y, Luo G, Yang W, Zhou L, Xie H. Antitumor effect and mechanism of AKT injection. Sichuan Daxue Xuebao (Medical Science Edition) 2008; 39: 500-502
14. Chen X, Yang L, Oppenheim JJ, Howard MZ. Cellular pharmacology studies of shikonin derivatives. Phytother Res 2002; 16: 199-209
15. Chen X, Yang L, Zhang N, Turpin JA, Buckheit RW, Osterling C, Oppenheim JJ, Howard OM. Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother 2003; 47: 2810-2816
16. Wu Z, Wu L, Li L, Tashiro S, Onodera S, Ikejima T. p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells. J Pharmacol Sci 2004; 94: 166-176
17. Yang F, Chen Y, Duan W, Zhang C, Zhu H, Ding J. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor. Int J Cancer 2006; 119: 1184-1193
18. Papageorgiou VP, Assimopoulou AN, Couladouros EA, Hepworth D, Nicolaou KC. The chemistry and biology of alkannin, shikonin, and related naphtazarin natural products. Angew Chem Int Edit 1999; 38: 270-300
19. Liu J, Zhou W, Li SS, Sun Z, Lin B, Lang YY, He JY, Cao X, Yan T, Wang L, Lu J, Han YH, Cao Y, Zhang XK, Zeng JZ. Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues. Cancer Res 2008; 68: 8871-8880
20. Mao X, Yu CR, Li WH, Li WX. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res 2008; 18: 879-888
21. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1326
22. Fan XQ, Guo YJ. Apoptosis in oncology. Cell Res 2001; 11: 1-7
23. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619
24. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74: 777-779